Table 1 The inclusion criteria and exclusion criteria
Inclusion criteria | Exclusion criteria |
|---|---|
Inclusion criteria for patients | |
a. Severe cognitive dysfunction, severe aphasia, cannot cooperate with the whole treatment or testing process | |
b. Age: 35 ~ 75 years old, male and female | b. Patients with serious primary diseases such as heart, lung, kidney, liver, and endocrine system |
c. Course of disease: 2 weeks to 3 months after stroke, stable vital signs, basically normal cognitive function, can cooperate to complete the test | c. Neurological or musculoskeletal diseases affecting functional recovery before onset |
d. Manual muscle test (MMT) ≥ 2 [17], modified Ashworth (MAS) [18] of paralyzed upper limbs are graded I ~ II | d. Cerebral stem stroke or bilateral stroke |
e. Body mass index (BMI) ≤ 28 | e. Patients with severe anxiety, depression, affective disorders, schizophrenia, and other serious mental disorders |
f. No serious heart, lung, kidney, and other functional damage; serious underlying diseases; pain in the affected side of the upper limb joint | f. Examination confirmed by brain tumor, brain trauma, brain parasitic diseases, metabolic disorders, rheumatic heart disease, coronary heart disease, and other heart diseases with atrial fibrillation caused by cerebral embolism |
g. The informed consent is signed by the patient and/or his/her family members. Note: patients who meet the above 7 criteria can be included in this study | g. Patients with skin damage, infection, or deformity at the treatment site |
Inclusion criteria for healthy subjects | |
a. Those who have been proven to be healthy by physical examination and have no organic lesions or obvious functional diseases | |
b. Age: 35 ~ 75 years old, male and female | |
c. No cold, fever, cough, headache, and other physical abnormalities during the test | |
d. Do not take any excitability drugs in the past 1 month, no recent treatment related to the trial content | |
e. No history of mental or nervous system | |
f. The subject agrees and signs the informed consent | |